Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: A systematic review

Cancer Medicine

Volumn 3, Issue 6, 2014, Pages 1502-1511

  Fiteni, Frédéric ^a   Nguyen, Thierry ^a   Vernerey, Dewi ^a   Paillard, Marie Justine ^a   Kim, Stefano ^a,b   Demarchi, Martin ^a,b   Fein, Francine ^a   Borg, Christophe ^a,c   Bonnetain, Franck ^a,d   Pivot, Xavier ^a,c  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b Radiotherapy Department   (France)

^c RIGHT Interactions Hôte Greffon Tumeur Ingénierie Cellulaire et Génique   (France)

^d UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Biliary tract cancer; Cisplatin; Gemcitabine; Oxaliplatin

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DEOXYCYTIDINE; GEMCITABINE; OXALIPLATIN; PLATINUM COMPLEX;

ANALOGS AND DERIVATIVES; BILIARY TRACT NEOPLASMS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILIARY TRACT NEOPLASMS; CISPLATIN; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84990929667     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.299     Document Type: Article

References (40)

1. Alvaro, D., M. C. Bragazzi, A. Benedetti, L. Fabris, G. Fava, P. Invernizzi, et al. 2011. Cholangiocarcinoma in Italy: a national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" Committee of the Italian Association for the Study of Liver disease. Dis. Liver Dis. 43:60-65.
2. Glimelius, B., K. Hoffman, P. O. Sjödén, G. Jacobsson, H. Sellström, L. K. Enander, et al. 1996. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann. Oncol. 7:593-600.
3. Rao, S., D. Cunningham, R. E. Hawkins, M. E. Hill, D. Smith, F. Daniel, et al. 2005. Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer. Br. J. Cancer 92:1650-1654.
4. Kornek, G. V., B. Schuell, F. Laengle, T. Gruenberger, M. Penz, K. Karall, et al. 2004. Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. Ann. Oncol. 15:478-483.
5. Ducreux, M., E. Van Cutsem, J. L. Van Laethem, T. M. Gress, K. Jeziorski, P. Rougier, et al. 2005. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial. Eur. J. Cancer 41:398-403.
6. Androulakis, N., G. Aravantinos, K. Syrigos, A. Polyzos, N. Ziras, E. Tselepatiotis, et al. 2006. Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: a multicenter phase II study. Oncology 70:280-284.
7. Eckel, F., and R. M. Schmid. 2007. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br. J. Cancer 96:896-902.
8. Valle, J., H. Wasan, D. H. Palmer, D. Cunningham, A. Anthoney, A. Maraveyas, et al. 2010. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N. Engl. J. Med. 362:1273-1281.
9. Sharma, A., A. D. Dwary, B. K. Mohanti, S. V. Deo, S. Pal, V. Sreenivas, et al. 2010. Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J. Clin. Oncol. 28:4581-4586.
10. Lee, J., S. H. Park, H.-M. Chang, J. S. Kim, H. J. Choi, M. A. Lee, et al. 2012. Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study. Lancet Oncol. 13:181-188.
11. Malka, D., L. Fartoux, V. Rousseau, T. Trarbach, E. Boucher, C. D. L. Fouchardiere, et al. 2012. Gemcitabine and oxaliplatin (GEMOX) alone or in combination with cetuximab as first-line treatment for advanced biliary cancer: final analysis of a randomized phase II trial (BINGO). J. Clin. Oncol. 30(Suppl); abstr 4032. Disponible sur: http://meetinglibrary.asco.org/content/100116-114 (accessed 30 October 2013).
12. Carraro, S. 2001. Gemcitabine and cisplatin in locally advanced or metastatic gallbladder and bile duct adenocarcinomas. Proc. Am. Soc. Clin. Oncol. 20 (abstract 2333).
13. Malik, I. A., Z. Aziz, S. H. M. Zaidi, and G. Sethuraman. 2003. Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder. Am. J. Clin. Oncol. 26:174-177.
14. Baluch, S., J. Lau, T. dhilon, H. S. Wasan. 2003. A well tolerated and highly effective regimen for locally advanced and metastatic biliary tract cancers with gemcitabine and cisplatin. Proc. Am. Soc. Clin. Oncol. 22 (abstract 1473).
15. Reyes-Vidal, J. 2003. Gemcitabine (G) and cisplatin (C) in the treatment of patients (pts) with unresectable or metastatic gallbladder cancer: results of the phase II GOCCHI study 2000-13. Proc. Am. Soc. Clin. Oncol. 22 (abstract 1095).
16. Doval, D. C., J. S. Sekhon, S. K. Gupta, J. Fuloria, V. K. Shukla, S. Gupta, et al. 2004. A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br. J. Cancer 90:1516-1520.
17. Thongprasert, S., S. Napapan, C. Charoentum, and S. Moonprakan. 2005. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann. Oncol. 16:279-281.
18. Kim, S. T., J. O. Park, J. Lee, K. T. Lee, J. K. Lee, S.-H. Choi, et al. 2006. A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer 106:1339-1346.
19. Giuliani, F., V. Gebbia, E. Maiello, N. Borsellino, E. Bajardi, G. Colucci, et al. 2006. Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM). Ann. Oncol. 17:(Suppl. 7):vii73-77.
20. Park, B. K., Y. J. Kim, J. Y. Park, S. Bang, S. W. Park, J. B. Chung, et al. 2006. Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. J. Gastroenterol. Hepatol. 21:999-1003.
21. Lee, J., T.-Y. Kim, M. A. Lee, M. J. Ahn, H.-K. Kim, H. Y. Lim, et al. 2008. Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. Cancer Chemother. Pharmacol. 61:47-52.
22. Meyerhardt, J. A., A. X. Zhu, K. Stuart, D. P. Ryan, L. Blaszkowsky, N. Lehman, et al. 2008. Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer. Dig. Dis. Sci. 53:564-570.
23. Charoentum, C., S. Thongprasert, B. Chewaskulyong, and S. Munprakan. 2007. Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma. World J. Gastroenterol. 13:2852-2854.
24. Valle, J. W., H. Wasan, P. Johnson, E. Jones, L. Dixon, R. Swindell, et al. 2009. Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. Br. J. Cancer 101:621-627.
25. Goldstein, D., M. C. Gainford, C. Brown, N. Tebbutt, S. P. Ackland, G. van Hazel, et al. 2011. Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. Cancer Chemother. Pharmacol. 67:519-525.
26. Okusaka, T., K. Nakachi, A. Fukutomi, N. Mizuno, S. Ohkawa, A. Funakoshi, et al. 2010. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br. J. Cancer 103:469-474.
27. Weatherly, J., K. Eckmann, D. Patel, A. N. Landgraf, J. H. Slade, R. A. Wolff, et al. 2011. Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis. J. Clin. Oncol. 29(Suppl. 4) (abstract 271).
28. Gebbia, N., F. Verderame, R. Di leo, D. Santangelo, G. Cicero, M. Valerio, et al. 2005. A phase II study of Oxaliplatin (O) and Gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers. J. Clin. Oncol., 2005 ASCO annual Meeting proceedings. Vol 23, No 16S, Part I of II (June 1 Supplement), 4132.
29. Harder, J., B. Riecken, O. Kummer, C. Lohrmann, F. Otto, H. Usadel, et al. 2006. Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer. Br. J. Cancer 95:848-852.
30. Verderame, F., A. Russo, R. Di Leo, G. Badalamenti, D. Santangelo, G. Cicero, et al. 2006. Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers. Ann. Oncol. 17(Suppl. 7):vii68-vii 72.
31. Manzione, L., R. Romano, and D. Germano. 2007. Chemotherapy with gemcitabine and oxaliplatin in patients with advanced biliary tract cancer: a single-institution experience. Oncology 73:311-315.
32. Kim, H. J., N. S. Lee, S.-C. Lee, S. B. Bae, C. K. Kim, Y. G. Cheon, et al. 2009. A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer. Cancer Chemother. Pharmacol. 64:371-377.
33. André, T., J. M. Reyes-Vidal, L. Fartoux, P. Ross, M. Leslie, O. Rosmorduc, et al. 2008. Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study. Br. J. Cancer 99:862-867.
34. Cassier, P. A., C. Thevenet, J. Souquet, T. Ponchon, J. Baulieux, C. Partensky, et al. 2008. Outcome of patients receiving chemotherapy for advanced biliary tract or gallbladder cancer. J. Clin. Oncol. 26(Suppl) (abstract 15627).
35. Jang, J.-S., H. Y. Lim, I. G. Hwang, H. S. Song, N. Yoo, S. Yoon, et al. 2010. Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial. Cancer Chemother. Pharmacol. 65:641-647.
36. Hollebecque, A., O. Bouché, O. Romano, E. Scaglia, S. Cattan, P. Zerbib, et al. 2010. Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma. Chemotherapy 56:234-238.
37. Sharma, A., B. Mohanti, V. Raina, N. Shukla, S. Pal, A. Dwary, et al. 2010. A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer. Cancer Chemother. Pharmacol. 65:497-502.
38. Fiteni, F., T. Nguyen, C. Borg, E. Dobi, F. Fein, A. Thierry-Vuillemin, et al. 2011. Biliary tract carcinomas: a retrospective analysis of first line chemotherapy based on platinum compounds and second line based on 5 fluorouracil. Eur. Soc. Med. Oncol. (abstract 6575).
39. Borad, M., S. Reddy, N. Bahary, H. Uronis, D. S. Sigal, A. L. Cohn, et al. 2012. Gastrointestinal tumors, non-colorectal. Ann. Oncol.. 23(Suppl. 9):ix224-ix257.
40. Malka, D., L. Fartoux, V. Rousseau, T. Trarbach, E. Boucher, C. D. L. Fouchardiere, et al. 2012. Gemcitabine and oxaliplatin (GEMOX) alone or in combination with cetuximab as first-line treatment for advanced biliary cancer: final analysis of a randomized phase II trial (BINGO). J. Clin. Oncol. 30(Suppl) (abstract 4032).